What is Danielle M. Lee’s total Bath & Body Works (BBWI) share ownership after the grant?

After the June 11, 2026 grant, Danielle M. Lee directly owns 26,181 shares of Bath & Body Works common stock. This total reflects the newly granted 7,970-share award in addition to her previously held shares.

Bath & Body Works director awarded 7,970 RSUs

Lee Danielle M. reported acquisition or exercise transactions in this Form 4 filing.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Lee Danielle M. reported acquisition or exercise transactions in this Form 4 filing.

Bath & Body Works, Inc. director Danielle M. Lee reported a compensation-related equity grant. On June 11, 2026, she received 7,970 shares of common stock at $0.00 per share as an annual award of restricted stock units granted to independent non-employee directors. Following this award, her direct holdings increased to 26,181 common shares. This is not an open-market buy or sell, but part of standard director equity compensation.

Insider Trade Summary

Grant/Award: 7,970 shares

Grant/Award 1 txn

Insider Lee Danielle M.

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock, $0.50 par value	7,970	$0.00	$0.00

Holdings After Transaction: Common Stock, $0.50 par value — 26,181 shares (Direct)

Footnotes (1)

F1. Annual award of restricted stock units to independent non-employee directors.

Key Figures

Shares granted: 7,970 shares Grant price: $0.00 per share Post-grant holdings: 26,181 shares

3 metrics

Shares granted 7,970 shares Annual award of restricted stock units on June 11, 2026

Grant price $0.00 per share Compensation grant, not an open-market purchase

Post-grant holdings 26,181 shares Total common shares directly owned after the award

Key Terms

restricted stock units, independent non-employee directors, Form 4

3 terms

restricted stock units financial

"Annual award of restricted stock units to independent non-employee directors."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

independent non-employee directors financial

"Annual award of restricted stock units to independent non-employee directors."

Form 4 regulatory

"INSIDER FILING DATA (Form 4): {"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Bath & Body Works (BBWI) report for Danielle M. Lee?

Bath & Body Works reported that director Danielle M. Lee received a grant of 7,970 shares of common stock as an annual restricted stock unit award. The grant is compensation, not an open-market stock purchase or sale.

How many Bath & Body Works (BBWI) shares were granted to Danielle M. Lee?

Danielle M. Lee was granted 7,970 shares of Bath & Body Works common stock. The filing describes this as an annual award of restricted stock units given to independent non-employee directors as part of their equity compensation program.

Was cash paid for the Bath & Body Works (BBWI) shares granted to Danielle M. Lee?

No cash was paid for these shares; the grant price was $0.00 per share. The shares were issued as an equity compensation award, classified as an annual restricted stock unit grant to an independent non-employee director.

Is Danielle M. Lee’s Bath & Body Works (BBWI) transaction a stock sale or purchase?

The transaction is neither a sale nor an open-market purchase. It is an acquisition of 7,970 shares through a grant or award of restricted stock units, which is standard equity compensation for independent non-employee directors.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 06/15/2026 - 04:20 PM EDT

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Lee Danielle M.

(Last)

(First)

(Middle)

THREE LIMITED PARKWAY

(Street)

COLUMBUS

OHIO

43230

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Bath & Body Works, Inc. [ BBWI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/11/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock, $0.50 par value	06/11/2026		A		7,970⁽¹⁾	A	$0.0000	26,181	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Annual award of restricted stock units to independent non-employee directors.

	Robert J. Tannous, Attorney-in-Fact	06/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR